Opportunity Description
About Us
Eupraxia is a clinical‑stage biotechnology company focused on developing locally delivered, extended‑release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere™, a proprietary polymer‑based micro‑sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs, providing an extended duration of effect in a hyper‑localized fashion. This precision targeting may reduce adverse events by delivering the active ingredient directly to the tissues physicians want to treat, improving the safety, tolerability, efficacy and duration of effect of FDA‑approved drugs. The technology’s potential spans beyond pain and inflammatory gastrointestinal disease to oncology, infectious disease and other critical disease areas.
EP‑104GI is currently in a Phase 1b/2 trial (RESOLVE) for eosinophilic esophagitis (EoE), administered as an injection into the esophageal wall for local de...
Interested in this opportunity? Apply now through Expertini.
Apply for this Position